The role of RIAM in T cell immunity and tolerance
The role of RIAM in T cell immunity and tolerance
批准号:
8707612
负责人:
VASSILIKI A BOUSSIOTIS
金额:
$40.89万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-15 至 2015-07-31
关键词:
ActinsAddressAdhesionsAffectAffinityAntigensAsthmaAutoimmunityAvidityBindingBiochemicalBlood PlateletsC-terminalCalciumCalcium ionCell CommunicationCell membraneCellsDistalEventFamilyGTP BindingGenerationsGoalsGraft RejectionGuanosine TriphosphateHypersensitivityImmune responseImmunityIntegrinsKnowledgeLCP2 geneLearningLifeMediatingMembraneMicroscopyModelingMolecularMusN-terminalNatureNuclear TranslocationOutputPH DomainPathway interactionsPhosphorylationProlineProteinsRecruitment ActivityRoleSH3 DomainsSignal TransductionSignaling MoleculeSiteSpatial DistributionSpecificityStructureT cell responseT-Cell ActivationT-LymphocyteTCR ActivationTherapeutic InterventionTumor AntigensUp-RegulationZAP-70 Genecellular imagingfunctional outcomesgenetic regulatory proteingraft vs host diseasein vivoinsightpathogenplatelet protein P47profilinrelease of sequestered calcium ion into cytoplasmresponsesmall hairpin RNAvasodilator-stimulated phosphoprotein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the present project is to study the role of RIAM, an adaptor molecule of the MRL family, in T cell responses. We identified and molecularly cloned RIAM (Rap1GTP-interacting adaptor molecule) through its association with active, GTP-bound Rap1. RIAM contains an N-terminal coiled-coil region, central Ras association (RA) and pleckstrin homology (PH) domains, and a proline-rich C-terminal region with multiple FPPPP motifs interacting with the EVH1 domains of the actin regulatory proteins Ena/VASP and multiple XPPPP motifs interacting with profilin. Through its interaction with Ena/VASP proteins RIAM functions as cytoskeletal regulator. RIAM is also implicated in activation of ?1 and ?2 integrins in T cells ?II?3 integrin in platelets. We determined that RIAM has an unexpected role in TCR-mediated signaling. RIAM interacts directly with PLC-?1 and is involved in the generation of inositole 1,4,5-trisphosphate (IP3), mobilization of intracellular calcium ions, nuclear translocation of NFAT and activation of Ras. Elimination of endogenous RIAM abrogated these events, although phosphorylation of ZAP-70 and formation of the SLP-76-LAT signalosome remained unaffected. We determined that the PH domain of RIAM has specificity for the PLC-?1 substrate, PI(4,5)P2, whereas the RA domain binds Rap1 only at the plasma membrane and not in the endomembrane compartments. Both the RA and PH domains have low affinity binding for their natural partners. Strikingly, the RA and PH domains are integrated into a single structural unit and binding of both RA and PH components to their natural partners is required for recruitment of RIAM to the plasma membrane. RIAM also interacts with Gads and undergoes Lck-mediated phosphorylation in its PH domain. Our results reveal an unexpected role of RIAM as a second and indispensable node of signal integration that is co-required with the SLP-76-LAT signalosome for activation of PLC-?1. The mechanisms via which RIAM regulates PLC-?1 activation remain unclear. It is also unclear how RIAM is integrated in signaling assemblies with other signaling molecules and whether the effects of RIAM on PLC-?1 activation would impact on actin reorganization and integrin avidity modulation thereby affecting T cell interaction dynamics and functional outcomes during antigen encounter. To address these questions we will undertake the Specific Aims described in the present proposal. Specific Aim 1: To dissect how RIAM regulates activation of PLC-?1. Specific Aim 2: To determine how RIAM regulates formation, distribution and signal output from signaling microclusters. Specific Aim 3: To examine how RIAM regulates TCR signaling, actin dynamics, integrin avidity modulation and interaction dynamics of primary T cells during stimulation by antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
-
批准号:10681034
-
项目类别:
-
资助金额:$67.26万
-
财政年份:2023
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
-
批准号:10605878
-
项目类别:
-
资助金额:$72.26万
-
财政年份:2023
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
-
批准号:10330481
-
项目类别:
-
资助金额:$59.12万
-
财政年份:2020
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
-
批准号:10547788
-
项目类别:
-
资助金额:$59.12万
-
财政年份:2020
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
-
批准号:10524100
-
项目类别:
-
资助金额:$4.44万
-
财政年份:2018
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
-
批准号:10198866
-
项目类别:
-
资助金额:$64.89万
-
财政年份:2018
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
-
批准号:10431932
-
项目类别:
-
资助金额:$63.6万
-
财政年份:2018
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Advancing Treatment Outcomes in Malignant Glioma by Integrating Immunotherapy and Standard of Care using Genetically Engineered Mice that Recapitulate Molecular Feature of Human Glioma
-
批准号:10377182
-
项目类别:
-
资助金额:$4.53万
-
财政年份:2018
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
-
批准号:9919516
-
项目类别:
-
资助金额:$57.1万
-
财政年份:2017
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
-
批准号:10152529
-
项目类别:
-
资助金额:$57.1万
-
财政年份:2017
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
-
批准号:8985871
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2013
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
-
批准号:8588715
-
项目类别:
-
资助金额:$57.39万
-
财政年份:2013
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
-
批准号:9314786
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2013
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
-
批准号:9272856
-
项目类别:
-
资助金额:$89.4万
-
财政年份:2013
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
-
批准号:8703046
-
项目类别:
-
资助金额:$52.08万
-
财政年份:2013
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Prevention of acute GvHD by inhibition of cdk2
-
批准号:8093452
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2011
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Prevention of acute GvHD by inhibition of cdk2
-
批准号:8250339
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2011
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
-
批准号:7405249
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2008
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
-
批准号:7694977
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2008
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
Expression and Function of Tob in T Lymphocytes
-
批准号:7060340
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2005
-
负责人:VASSILIKI A BOUSSIOTIS
-
依托单位:
海外基金